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Hospital-acquired bloodstream infections 
Hospital outbreaks of Pseudomonas 
aeruginosa and Acinetobacter baumannii 
bacteremic infections 
U. Frank. Institutfner Umweltmedizin nnd Krankcnhanshygiene, 
Lirtiversitaetskliniken Freiburz, Freibuv, Germany 
Pseudomonas aenrginosa and other non-fernrenting Gram-negative 
bacilli such as rlrinetobactcl- batrmannii have been recognized as 
important pathogens in hospital infections, with several reports of 
outbreaks in various settings. In epidemic situations, I! aeruginosa and 
A. baumannii have been noted to spread from contaminated common 
sources to persons as well as from person to person. The development 
of molecular typing methods has given the clinical microbiology 
laboratory powerful tools, thus providing the ineans for better 
understanding of the epidemiology of infections caused by these 
organisms. Bacteremia tends to occur in patents with impaired host 
defenses who have intravenous catheters and are receiving broad- 
spectrum antibiotics. While I! aenrginosa bacteremia is almost always 
life-threatening, bacteremia caused by A .  bairniannii has the dual 
potential to present as very low-grade infection or septic shock. I! 
aeruginosa and A. banmanriii isolates are resistant to many commonly 
used antibiotics, including first- and second-generation cephalo- 
sporins; only advanced beta-lactani antibiotics, aminoglycosides, and 
tluoroquinolones offer useful antimicrobial activity. Prevention and 
control of bacteremic infections caused by non-fermenting Gram- 
negative bacilli requires attention to many aspects of patient care and 
the hospital environment. 
w] A critical review of the efficacy of measures for 
preventing bloodstream infection 
R.C. Spencer. Public Health hborilfory, Brisfol Royal Ittfirmary, 
Brisfol, UK 
Over the past two decades the occurrence of bloodstream infections 
in hospitalized patients has increased. Gram-positive bacteria have 
emerged as the predominant nosocomial bloodstream infecting 
pathogens, while Gram-negative bacteria continue to decline. To 
compound these problems, antimicrobial resistance, long considered 
the domain of nosocomial Gram-negative microorganisms, is being 
increasingly exhibited by Gram-positive isolates. The attack rates for 
bloodstream infections range from 1.3 to 14.S per 1000 hospital 
admissions, varying with the type of patient population studied, 
underlying diseases, extremes of age, size of hospital, length of 
hospital stay, use of indwelling devices, ward location of the patient 
within a hospital and the prevalent types of infecting microorganisms. 
The evolving role of Gram-positive bloodstream infection is related 
to the high numbers of neutropenic/imniunocompromised patients, 
widespread use of indwelling vascular and urinary catheters, and 
increased use of antibiotics with anti-Gram-negative spectra. The risk 
factors specific to nosocomial bloodstream pathogens such as 
coagulase-negative staphylococci, MRSA, enterococci (especially 
VRE),and yeasts will be presented and discussed. The measures 
available for preventing nosocomial bloodstream infection include: 
the restriction of the use of broad-spectrum antibiotics; infection 
control measures; insertion and maintenance of intravascular and 
urinary catheters; advances in the design and constituents of in- 
dwelling catheters such as incorporation of metals, antiseptics or 
antibiotics; and the role of active surveillance of infecting micro- 
organisms and their antimicrobial susceptibility 
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Epidemicity and pathogenicity markers of 
Haemophilus influenzae 
A. van Belkum. Erasrnus Chiiiersity Medical Center Rotterdam, 
Departni~nf o Medical Microbiology G Injcrious Diseases, Rotterdam, 
The Nerlierlands 
Haemophilus intluenzae is of considerable clinical concern in specific 
groups of patients. For this reason, many investigations into its patho- 
genicity and epidemcity have been performed. The availability of 
the whole genome sequence has enabled these analyses to be per- 
formed in unprecedented detail. Complete sets of genes involved in 
the biosynthesis of virulence factors such as the lipopolysaccharide 
(LPS) could be identified and studied for their individual contri- 
bution to disease development in animal models of infection (Hood 
et al. Proc Natl Acad Sci USA 1996; 93: 11121-5). In addition, 
within the genome sequence potentially variable regions could be 
identified on the basis of the presence of repetitive DNA moieties. 
The usefulness for strain identification and tracking outbreak-related 
isolates of H .  iq'lnenzae of these loci was documented (Van Belkum 
et al. Infect Immun 1997; 65: 5017-27). In addition, it appeared that 
most if not all of the DNA reprat-containing regions were either in 
the close proximity of or even within the coding regions of potential 
virulence genes. The prime 'function' of the repeats lies in their 
potential to affect gene expression by altering either transcription 
efficiency or translational reading frames. Despite the functional con- 
straint posed upoii these regions, they still serve as useful molecular 
markers, in the end not only enabling the determination of evolu- 
tionary clock speed, but also facilitating the tracking of strains of H. 
intuenzae. The combination of assessing virulence characteristics and 
general genotypes might have important diagnostic medical- 
microbiological imphcations. 
Streptococcal toxic shock syndrome: virulent 
clones and/or susceptible host? 
M. Kotb. ICferans AJair, Medical Center, Memphis, TN, USA 
The numbers of streptococcal toxic shock (STSS) and necrotizing 
fasciitis (NF) cases continue to rise. Despite numerous studies, no 
satisfactory explanation for the renewed virulence of group A 
streptococci (GAS) has yet emerged-has the bacterium acquired 
new virulence and novel superantigens (SAP), or has host suscepti- 
bility been altered? These possibilities are not mutually exclusive; 
however, our recent studies of 300 cases showed that patients with 
invasive streptococcal infections, caused by genotypically indistin- 
guishable strains, can develop either severe (hypotension and multi- 
organ failure, e.g. STSS and STSS/NF) or non-severe invasive disease 
(no hypotension or organ failure, e.g. bacteremia/ceIlulitis). These 
observations strongly suggest that host factors play a pivotal role in 
determining the severity of systemic manifestations of invasive GAS 
infection. 
The pathogenesis of severe invasive GAS infections is believed to 
be mediated by streptococcal Sags, which together with streptococcal 
proteases can trigger potent release of inflammatory cytokinec that 
mediate tissue damage, organ failure, and shock. It is reasonable to 
propose that host factors that affect SAg responses are likely to 
modulate disease severity. The levels of antibodies (Abs) that can 
opsonize the bacteria or neutralize the activity of the SAgs that they 
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produce were determined in plasma of severe and non-severe invasive 
cases caused by the same M l T l  strain. The data showed that low 
levels of protective Abs might render the host susceptible to invasive 
streptococcal infection, but that the lack of these antistreptococcal 
Abs is not a factor in determining disease severity. 
Host immunogenetic factors, namely class I1 allotype and T cell 
receptor VB expression profile, control immune responses to SAgs, 
and consequently can affect the magnitude of the acute in vivo 
inflammatory response atid the severity of systemic manifestations in 
invasive disease. We investigated the HLA association with the severe 
and nonsevere form of the disease in 200 cases of invasive group A 
streptococcal infection. Results indicated that while certain haplo- 
types strongly increase the risk of severe disease, others seem to be 
protective. The molecular basis of this phenomenon was investigated 
and the findings suggest that the HLA allotype can affect signaling by 
superantigens and consequently control the magnitude of the 
proliferative and cytokine response as well as the cytokine Thl /Th2 
profile. 
vl Meningococcal epidemics: the dynamics of 
antigenic diversity and clonal spread 
D.A. Caugant. National Institute of Public Health, Bacteriology, Oslo, 
Norway 
Epidemics and hyperendemic waves of nieningococcal disease are 
associated with the spread of a single virulent clone in a susceptible 
population. Although hundreds of clones of Neisseria menbyitidis have 
been identified in patients, less than 10 clone complexes cause most 
of the disease worldwide. 
Large-scale epidemics caused by serogroup A organisms are the 
most serious public-health burden, requiring considerable resources 
to control in parts of the world where these are severely limited. 
Serogroup A N meningitidis strains are essentially a restricted sub- 
population of the species that recently arose from a common ancestor 
and possess a limited antigenic repertoire. Serogroup A meningococci 
of subgroup 111 have been responsible for two pandemics both 
starting in China, 15 years apart. The last pandemic is still ongoing 
in the African continent. Limited genetic variation leading to 
antigenic changes has been found within subgroup I11 strains. 
Starting in the iiiid-1970k hyperendemic waves of disease caused 
by clones of the ET-5 complex were seen in Europe and the 
Americas. Kecent data suggest also an Asian origin of this group of 
clones. In contrast to the relative stability of serogroup A strains of 
subgroup 111, dramatic genetic and antigenic changes occurred 
during the spread of this group of clones. Sequence analysis of the 
genes coding for several outer membrane proteins have revealed a 
large amount ofmicro-heterogeneity among strains of the ET-5 com- 
plex. Some minor changes in the epitope region of antigenic struc- 
tures appeared as an escape mechanism to avoid the immune pressure 
of the human host. Thus, repeated antigenic variation arises during 
the epidemic spread of meningococcal clones through point muta- 
tions, translocation and horizontal genetic exchange. 
[ml Virulence and epidemiology of Burkholderia 
cepacia in cystic fibrosis 
J.R.W. Govan. Medical School, Dept. ofMedical Microbiology, 
Edinburgh, U K  
In individuals with cystic fibrosis, pulmonary colonization with 
Burkholderia cepacia reduces survival by 50%, and approximately one- 
third of patients succumb to ‘cepacia syndrome’, a rapidly fatal necro- 
tizing pneumonia, sometimes accompanied by septicemia. These 
problems are exacerbated by the organism‘s inherent resistance to 
antibiotics, including human defensins, and the spread of epidemic 
strains. Ironically, B. cepacia produces potent antifungal activity and is 
attracting considerable interest from the agricultural industry 2s a 
biological control agent. Integrated genomic and phenotypic analyses 
have shown that isolates currently identified ac R. ccpatia belong to at 
least five distinct genomic species or genomovars, referred to 
collectively as the B. cepacia complex. All five genoniovarc have been 
cultured from humans; however, epidemic spread is nioct closely 
associated with genomovar Ill, possession ofcable-like pill and a novel 
DNA marker, termed BCESM. Relatively little is known of the 
pathogenesis underlying the severe inflammatory response and 
systemic invasion observed in some patients, or of why clinical out- 
come varies from asymptomatic to fatal even in patients colonized hy 
the same epidemic clone. In vitro studies indicate that B. r e p i n  lipo- 
polysaccharide and a lipopeptide exotoxin ctimulate activation and 
degranulation of human neutrophils, suggesting that cepacia syn- 
drome may result from disturbance in apoptocic and the normal 
balance of inflammatory responses. Genomic fingerprinting, includ- 
ing PFGE and RAPD analyses in association with studiec of the 
genoniic plasticity and virulence potential of human and environ- 
mental isolates of the B. cepacia complex, provides a paradigm for the 
emergence of pathogenicity in inherently resistant coil microbes. 
[s1571 Molecular epidemiology of Bordetella pertussis 
endemic and epidemic infections 
N. Guiso. Laboratoire der Bordetella, Institut Pasteur, Paris, France 
Objectives: To analyze Bordetella pertussis isolates collected before 
and after 30 years of vaccination with a pertussis whole-cell vaccine 
and to compare them to vaccinal strains. 
Methods: Borderella pertussis clinical isolates were collected 
between 1990 and 1997 as part of the surveillance of whooping 
cough in France, and compared to the isolates collected before the 
introduction of generalized vaccination and to vaccinal strains. 
Expression of bacterial strains such as pertussis toxin (I’T) and 
adenyiate cyclase-hemolysin (AC-Hly), and of bacterial adhesins 
such as filamentous hemagglutinin (FHA), pertactin (PKN) and 
fimbriae (FIM2 and 3), was performed using poly- and monoclonal 
antibodies. Bacterial DNA fragments were analyzed by pulsed-field 
gel electrophoresis (PFGE) after cleavage with restriction enzymes 
Spel  and XbaI. Sequencing of some part5 of the ctructural genes 
encoding the PT S 1 subunit and P R N  was also performed. 
Results: All isolates express PT and AC-Hly toxins, and FHA and 
P R N  adhesins. Most of the isolates express FIM3 but not FlM2. 
Using PFGE, isolates were found to be closely related to one another 
and to one of the vaccinal strains. However, ucing the neighbor- 
joining distance method, isolates could be classified. Four major 
groups could be obtained. Sequencing of the p r ~ i  structural genes 
showed that three of these groups contained isolates expressing 
different PRNs. Furthermore, isolates collected before the use of 
vaccination express a different PT S 1 subunit. 
Conclusions: PFGE is a very discriminative technique allowing 
classification of clinical isolates and surveillance of the emergence of 
isolates that could be different from vaccinal strains. 
